Penicillin G-resistant viridans group streptococcal endocarditis and interpretation of the American Heart Association's Guidelines for the Treatment of Infective Endocarditis.
We report a case of endocarditis due to a penicillin-"resistant" Streptococcus parasanguinis, discuss interpretations of the American Heart Association's guidelines for the treatment of viridans group streptococcal infection, and comment on therapy for infective endocarditis due to penicillin-resistant viridans group streptococci.
Fujitani
Shigeki
S
University of California-Los Angeles (UCLA)-Affiliated Infectious Diseases Fellowship Training Program, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.
Rowlinson
Marie-Claire
MC
George
W Lance
WL
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004697:Endocarditis, Bacterial / Q000382:microbiology*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010400:Penicillin G / Q000494:pharmacology*; D010403:Penicillin Resistance; D017410:Practice Guidelines as Topic; D013290:Streptococcal Infections / Q000382:microbiology*; D034363:Viridans Streptococci / Q000187:drug effects* / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D010400:Penicillin G